about
Inflammatory arthritis in HIV positive patients: A practical guideEffect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in UgandaCD45 variant alleles: possibly increased frequency of a novel exon 4 CD45 polymorphism in HIV seropositive UgandansChanges in Mycobacterium tuberculosis genotype families over 20 years in a population-based study in Northern MalawiControl of (multi)drug resistance and tuberculosis incidence over 23 years in the context of a well-supported tuberculosis programme in rural MalawiHuman Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern MalawiDetection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control studyProfile: the Karonga Health and Demographic Surveillance SystemChallenges in reducing group B Streptococcus disease in African settings.HIV in Africa (Communication arising): chemokine-receptor genes and AIDS risk.The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level--a comparative analysis of data from four settings in Southern and East Africa.Ecological assessment of the direct and indirect effects of routine rotavirus vaccination in Merseyside, UK using data from multiple health systems: a study protocol.The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi.Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.Blood culture collection technique and pneumococcal surveillance in Malawi during the four year period 2003-2006: an observational studyCharacterising B cell numbers and memory B cells in HIV infected and uninfected Malawian adults.Epidemiological and Molecular Characterization of an Invasive Group A Streptococcus emm32.2 Outbreak.Population-level reduction in adult mortality after extension of free anti-retroviral therapy provision into rural areas in northern Malawi.Age at menarche, schooling, and sexual debut in northern Malawi.Diagnosis of childhood tuberculosis and host RNA expression in Africa.Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi.A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adultsGenetic changes during laboratory propagation: copy number At the reticulocyte-binding protein 1 locus of Plasmodium falciparum.Assessing the validity of sexual behaviour reports in a whole population survey in rural Malawi.Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected UgandansCombining qualitative and quantitative evidence to determine factors leading to late presentation for antiretroviral therapy in Malawi.Coreceptor usage, diversity, and divergence in drug-naive and drug-exposed individuals from Malawi, infected with HIV-1 subtype C for more than 20 years.Molecular detection of mixed infections of Mycobacterium tuberculosis strains in sputum samples from patients in Karonga District, Malawi.Fertility intentions and use of contraception among monogamous couples in northern Malawi in the context of HIV testing: a cross-sectional analysis.Characterizing the emergence and persistence of drug resistant mutations in HIV-1 subtype C infections using 454 ultra deep pyrosequencingDrug resistance mutations in drug-naive HIV type 1 subtype C-infected individuals from rural MalawiHigh mortality amongst adolescents and adults with bacterial meningitis in sub-Saharan Africa: an analysis of 715 cases from MalawiUse of pneumococcal polysaccharide vaccines: no simple answers.The effect of HIV and antiretroviral therapy on characteristics of pulmonary tuberculosis in northern Malawi: a cross-sectional studyMaternal HIV status associated with under-five mortality in rural Northern Malawi: a prospective cohort study.A reduction in adult blood stream infection and case fatality at a large African hospital following antiretroviral therapy roll-out.Normal Range of CD4 Cell Counts and Temporal Changes in Two HIVNegative Malawian Populations.Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study.Reverse transcriptase drug resistance mutations in HIV-1 subtype C infected patients on ART in Karonga District, Malawi.Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi.
P50
Q28072035-89EB3F4A-D03D-424B-B0CC-DFC0605F6F59Q28217042-0663BE87-1E1D-40FF-B60B-FBD8704271A5Q28254005-61D8F135-EDBC-40D0-9B05-80C07C8677CDQ28475188-71777F5A-6DEE-4536-86DA-3C29B5E3F9FFQ28487692-125A92CA-D763-4CC0-82F4-C7518D8EC29CQ28547873-B38D03D5-26CF-445E-AD5E-6308BC4F57B6Q28662246-506B4B0C-D192-4EC1-91AA-32AC9DDEB721Q28727176-A92881DA-F47E-42C8-B7B4-28BD35EDDCBBQ30241490-949DB136-6A69-4976-BE13-1A41565567A4Q30330292-C31EDF47-C113-4E7B-8B72-4652CE58C936Q30560890-7B6FC32D-04BF-4A87-AF94-036802D7B0C0Q30872011-B8D0E4E7-D87D-45F7-9072-B09DEC919839Q31032219-174E9C2F-A490-4899-BC5E-9B7ADAAF2DB0Q31072142-154E03C5-4C31-4048-90BD-D2367D04BA9BQ33375850-52760301-04E4-419C-BD24-854BCC5D2CF4Q33699375-4D1C5D8C-2D74-4BE2-AB2E-A6543FD13C2FQ33721528-076E7AD8-65C8-44E4-9592-5B8FD6322F33Q33728235-7E52A93D-6862-4FC2-A23C-0E93CF1CC8F5Q33769098-58F18BBE-40AF-4AD6-B0A7-C47ECBB770E7Q33803127-144A404A-C553-4E23-A213-D4851645A4F5Q33851271-D676B268-29E9-4E8F-A1F5-A730326DC5AEQ33864631-ECEC1442-7CF5-49EE-B328-C8351395ACB6Q33872804-71358ABA-AEA4-4A2C-A1BF-DD0A159870FDQ33983486-04A42416-E75F-42D4-B687-17D4443AD06AQ34072411-843978F4-9EDF-4191-B478-DE9404885977Q34082969-E85FFB1D-B634-434A-80EC-8CABE4794A50Q34269253-E783355C-F5C7-4E57-8152-AD223F6EA527Q34433086-F5407FFF-9B2E-49B0-B6F3-D737EAD067DCQ34532402-6ED19330-BF43-4E72-A256-22E5B2FB4AD0Q34567556-BBAE901B-4240-43CB-AA6F-B826C6B20414Q34748144-0E881D62-1D87-432E-AAD1-58E179BA75C5Q34874445-C8F3CA4E-D415-412C-895B-5AA99F775240Q35084394-9C79FB06-001E-4DC9-9586-AAE7BB04D30AQ35102704-C3A39ECA-5B24-4DA7-9612-5372FAE1F854Q35114447-651E12C1-AD45-4B4F-BBDF-95C683BD8D9EQ35124323-31E6B062-C0BB-4EE5-B33A-D3D24392E938Q35182289-7404E461-556A-4F68-8B06-87E78DD109BDQ35217987-61E4C6BD-3E83-44BA-9F9F-28603B3AAE21Q35548657-F3AAF914-1DE2-4900-89CF-A0C7FDC53C8EQ35635402-D47E78D7-F228-4411-AFF4-A4BB24DC7DEA
P50
description
researcher ORCID ID = 0000-0003-4814-8293
@en
wetenschapper
@nl
name
Neil French
@ast
Neil French
@en
Neil French
@es
Neil French
@nl
type
label
Neil French
@ast
Neil French
@en
Neil French
@es
Neil French
@nl
prefLabel
Neil French
@ast
Neil French
@en
Neil French
@es
Neil French
@nl
P1153
34975060700
P21
P31
P496
0000-0003-4814-8293